Biochips - Global Market Outlook (2015-2022)

Biochips - Global Market Outlook (2015-2022)

  • Published: May 2016
  • ID: SMRC15716

According to Stratistics MRC, the Bio Chip Market accounted for $7.35 billion in 2015 and is expected to grow at a CAGR of 19.6% to reach $25.8 billion by 2022. Increasing number of applications in drug discovery euipments, high precision of diagnosis treatments, growing number of cancer treatments leads to the usage of personalized medicine and high advancements in technology are some of the factors driving the market growth. However, unclear guiding principles, lack of awareness of biochips among rural communities and high cost of products are the restraints hampering the market growth during the forecast period. Considerable growth prediction in emerging countries such as China and India act as a opportunity for the biochip market.

DNA biochips segment is expected to witness the highest CAGR across the globe due to its growing applications in biotechnology and drug discovery. North America region is estimated to have largest share across globe, attributed to its factors such as growing aging population and growing incidence of diseases. On the other hand, Asia-Pacific is anticipated to grow at the highest CAGR over the forecast period. 

Some of the key players in global Bio Chip market include Abbott Laboratories, Agilent TechnologiesInc., Perkinelmer, Inc., Fluidigm Corporation, Roche Diagnostics, Thermo Fisher Scientific Inc., Cepheid Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Affymetrix Inc., Beckman Coulter Inc., Life Technologies Corp, Roche, Life Technologies Corp and Biomerieux SA.

Products Covered:              
• Micro array
o Lab-On-A-Chip microarray
o Protein Microarray 
o Other Protein Microarray
o DNA Microarray   
o Other Microarray Types
o Tissue Biochips
o Carbohydrate Biochips
• Microfluidics
• Analysis Software
• Biochip instruments
• Biochip reagents

End Users Covered:
• Academic & Research Institute
• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostics Centres
• Other End Users

Applications Covered:
• Diagnostic Applications
o Immune disease diagnostic
o Neurological diagnostic
o Cardiac diagnostic
o Other Applications
• Drug Discovery
o Structural Biology
o Lead Optimization
o Preclinical and Clinical Trial
o Process R&D
• Genomics
• Proteomics
• Other Applications

Functions Covered:
• Micro-RNA
• Gene Expression
• Epigenetic
• Genotyping
• Sequence Capture

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary   
     
2 Preface 
   
 2.1 Abstract   
 2.2 Stake Holders  
 2.3 Research Scope  
 2.4 Research Methodology 
  2.4.1 Data Mining 
  2.4.2 Data Analysis 
  2.4.3 Data Validation 
  2.4.4 Research Approach 
 2.5 Research Sources  
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions 
     
3 Market Trend Analysis  
 3.1 Introduction  
 3.2 Drivers   
 3.3 Restraints  
 3.4 Opportunities  
 3.5 Threats   
 3.6 Product Analysis  
 3.7 End User Analysis  
 3.8 Application Analysis 
 3.9 Emerging Markets  
     
4 Porters Five Force Analysis  
 4.1 Bargaining power of suppliers 
 4.2 Bargaining power of buyers 
 4.3 Threat of substitutes 
 4.4 Threat of new entrants 
 4.5 Competitive rivalry  
     
5 Global BioChips Market, By Product   
 5.1 Introduction  
 5.2 Microarray    
  5.2.1 Lab-On-A Chip Microarray
   5.2.1.1 Drug Discovery
   5.2.1.2 Genomics
   5.2.1.3 Proteomics
   5.2.1.4 Clinical Diagnostics
   5.2.1.5 IVD & POC
   5.2.1.6 Other Lab-On-A Chip Microarray
  5.2.2 Protein Microarray 
   5.2.2.1 High-Throughput Screening
   5.2.2.2 Expression Profiling
   5.2.2.3 Drug Discovery
   5.2.2.4 Diagnostics
   5.2.2.5 Proteomics
   5.2.2.6 Other Protein Microarray
  5.2.3 DNA Microarray 
   5.2.3.1 Agricultural Biotechnology
   5.2.3.2 Genomics
   5.2.3.3 SNP Genotyping
   5.2.3.4 Drug Discovery
   5.2.3.5 Cancer Diagnosis & Treatment
   5.2.3.6 Gene Expression
   5.2.3.7 Other DNA Chip Applications
  5.2.4 Other Microarray Types
   5.2.4.1 Cell Arrays
   5.2.4.2 Tissue Arrays
  5.2.5 Tissue Biochips 
  5.2.6 Carbohydrate Biochips
 5.3 Microfluidics   
 5.4 Analysis Software  
 5.5 Biochip instruments 
 5.6 Biochip reagents  
     
6 Global BioChips Market, By End User   
 6.1 Introduction  
 6.2 Hospitals and Diagnostics Centers 
 6.3 Biotechnology and Pharmaceutical Companies
 6.4 Academic & Research Institutes 
 6.5 Other End User  
     
7 Global BioChips Market, By Application  
 7.1 Introduction  
 7.2 Diagnostic Applications  
  7.2.1 Immune disease diagnostic
  7.2.2 Neurological diagnostic
  7.2.3 Cardiac diagnostic 
  7.2.4 Other Applications 
 7.3 Drug Discovery  
  7.3.1 Structural Biology 
  7.3.2 Lead Optimization 
  7.3.3 Preclinical and Clinical Trial
  7.3.4 Process R&D 
 7.4 Genomics   
 7.5 Proteomics  
 7.6 Other Applications  
     
8 Global BioChips Market, By Function  
 8.1 Introduction  
 8.2 Micro-RNA  
 8.3 Gene Expression  
 8.4 Epigenetic  
 8.5 Genotyping  
 8.6 Sequence Capture  
     
9 Global BioChips Market, By Geography 
 9.1 North America  
  9.1.1 US  
  9.1.2 Canada  
  9.1.3 Mexico  
 9.2 Europe   
  9.2.1 Germany  
  9.2.2 France  
  9.2.3 Italy  
  9.2.4 UK  
  9.2.5 Spain  
  9.2.6 Rest of Europe 
 9.3 Asia Pacific  
  9.3.1 Japan  
  9.3.2 China  
  9.3.3 India  
  9.3.4 Australia  
  9.3.5 New Zealand 
  9.3.6 Rest of Asia Pacific 
 9.4 Rest of the World  
  9.4.1 Middle East 
  9.4.2 Brazil  
  9.4.3 Argentina 
  9.4.4 South Africa 
  9.4.5 Egypt  
     
10 Key Developments   

 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers 
 10.3 New Product Launch 
 10.4 Expansions  
 10.5 Other Key Strategies 
     
11 Company Profiling   
 11.1 Abbott Laboratories         
 11.2 Agilent Technologies, Inc.        
 11.3 Perkinelmer, Inc.         
 11.4 Fluidigm Corporation         
 11.5 Roche Diagnostics         
 11.6 Thermo Fisher Scientific, Inc.        
 11.7 Cepheid Inc.           
 11.8 Bio-Rad Laboratories Inc.         
 11.9 GE Healthcare           
 11.10 Illumina, Inc.           
 11.11 Affymetrix Inc          
 11.12 Beckman Coulter Inc        
 11.13 Life Technologies Corp        
 11.14 Biomerieux SA 


List of Tables    
1 Global BioChips Market Outlook, By Region (2013-2022) ($MN)
2 Global BioChips Market Outlook, By Product (2013-2022) ($MN)
3 Global BioChips Market Outlook, By Microarray   (2013-2022) ($MN)
4 Global BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
5 Global BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
6 Global BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
7 Global BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
8 Global BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
9 Global BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
10 Global BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
11 Global BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
12 Global BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
13 Global BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
14 Global BioChips Market Outlook, By End User (2013-2022) ($MN)
15 Global BioChips Market Outlook, By Hospitals and Diagnostics Centers  (2013-2022) ($MN)
16 Global BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
17 Global BioChips Market Outlook, By Academic & Research Institutes  (2013-2022) ($MN)
18 Global BioChips Market Outlook, By Other End User (2013-2022) ($MN)
19 Global BioChips Market Outlook, By Application (2013-2022) ($MN)
20 Global BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
21 Global BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
22 Global BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
23 Global BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
24 Global BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
25 Global BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
26 Global BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
27 Global BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
28 Global BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
29 Global BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
30 Global BioChips Market Outlook, By Genomics  (2013-2022) ($MN)
31 Global BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
32 Global BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
33 Global BioChips Market Outlook, By Function (2013-2022) ($MN)
34 Global BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
35 Global BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
36 Global BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
37 Global BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
38 Global BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)
39 North America BioChips Market Outlook, By Country (2013-2022) ($MN)
40 North America BioChips Market Outlook, By Product (2013-2022) ($MN)
41 North America BioChips Market Outlook, By Microarray   (2013-2022) ($MN)
42 North America BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
43 North America BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
44 North America BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
45 North America BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
46 North America BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
47 North America BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
48 North America BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
49 North America BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
50 North America BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
51 North America BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
52 North America BioChips Market Outlook, By End User (2013-2022) ($MN)
53 North America BioChips Market Outlook, By Hospitals and Diagnostics Centers  (2013-2022) ($MN)
54 North America BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
55 North America BioChips Market Outlook, By Academic & Research Institutes  (2013-2022) ($MN)
56 North America BioChips Market Outlook, By Other End User (2013-2022) ($MN)
57 North America BioChips Market Outlook, By Application (2013-2022) ($MN)
58 North America BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
59 North America BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
60 North America BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
61 North America BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
62 North America BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
63 North America BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
64 North America BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
65 North America BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
66 North America BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
67 North America BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
68 North America BioChips Market Outlook, By Genomics  (2013-2022) ($MN)
69 North America BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
70 North America BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
71 North America BioChips Market Outlook, By Function (2013-2022) ($MN)
72 North America BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
73 North America BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
74 North America BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
75 North America BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
76 North America BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)
77 Europe BioChips Market Outlook, By Country (2013-2022) ($MN)
78 Europe BioChips Market Outlook, By Product (2013-2022) ($MN)
79 Europe BioChips Market Outlook, By Microarray   (2013-2022) ($MN)
80 Europe BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
81 Europe BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
82 Europe BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
83 Europe BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
84 Europe BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
85 Europe BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
86 Europe BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
87 Europe BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
88 Europe BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
89 Europe BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
90 Europe BioChips Market Outlook, By End User (2013-2022) ($MN)
91 Europe BioChips Market Outlook, By Hospitals and Diagnostics Centers  (2013-2022) ($MN)
92 Europe BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
93 Europe BioChips Market Outlook, By Academic & Research Institutes  (2013-2022) ($MN)
94 Europe BioChips Market Outlook, By Other End User (2013-2022) ($MN)
95 Europe BioChips Market Outlook, By Application (2013-2022) ($MN)
96 Europe BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
97 Europe BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
98 Europe BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
99 Europe BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
100 Europe BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
101 Europe BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
102 Europe BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
103 Europe BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
104 Europe BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
105 Europe BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
106 Europe BioChips Market Outlook, By Genomics  (2013-2022) ($MN)
107 Europe BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
108 Europe BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
109 Europe BioChips Market Outlook, By Function (2013-2022) ($MN)
110 Europe BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
111 Europe BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
112 Europe BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
113 Europe BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
114 Europe BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)
115 Asia pacific BioChips Market Outlook, By Country (2013-2022) ($MN)
116 Asia pacific BioChips Market Outlook, By Product (2013-2022) ($MN)
117 Asia pacific BioChips Market Outlook, By Microarray   (2013-2022) ($MN)
118 Asia pacific BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
119 Asia pacific BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
120 Asia pacific BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
121 Asia pacific BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
122 Asia pacific BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
123 Asia pacific BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
124 Asia pacific BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
125 Asia pacific BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
126 Asia pacific BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
127 Asia pacific BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
128 Asia pacific BioChips Market Outlook, By End User (2013-2022) ($MN)
129 Asia pacific BioChips Market Outlook, By Hospitals and Diagnostics Centers  (2013-2022) ($MN)
130 Asia pacific BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
131 Asia pacific BioChips Market Outlook, By Academic & Research Institutes  (2013-2022) ($MN)
132 Asia pacific BioChips Market Outlook, By Other End User (2013-2022) ($MN)
133 Asia pacific BioChips Market Outlook, By Application (2013-2022) ($MN)
134 Asia pacific BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
135 Asia pacific BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
136 Asia pacific BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
137 Asia pacific BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
138 Asia pacific BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
139 Asia pacific BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
140 Asia pacific BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
141 Asia pacific BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
142 Asia pacific BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
143 Asia pacific BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
144 Asia pacific BioChips Market Outlook, By Genomics  (2013-2022) ($MN)
145 Asia pacific BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
146 Asia pacific BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
147 Asia pacific BioChips Market Outlook, By Function (2013-2022) ($MN)
148 Asia pacific BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
149 Asia pacific BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
150 Asia pacific BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
151 Asia pacific BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
152 Asia pacific BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)
153 RoW BioChips Market Outlook, By Country (2013-2022) ($MN)
154 RoW BioChips Market Outlook, By Product (2013-2022) ($MN)
155 RoW BioChips Market Outlook, By Microarray   (2013-2022) ($MN)
156 RoW BioChips Market Outlook, By Lab-On-A Chip Microarray (2013-2022) ($MN)
157 RoW BioChips Market Outlook, By Protein Microarray (2013-2022) ($MN)
158 RoW BioChips Market Outlook, By DNA Microarray (2013-2022) ($MN)
159 RoW BioChips Market Outlook, By Other Microarray Types (2013-2022) ($MN)
160 RoW BioChips Market Outlook, By Tissue Biochips (2013-2022) ($MN)
161 RoW BioChips Market Outlook, By Carbohydrate Biochips (2013-2022) ($MN)
162 RoW BioChips Market Outlook, By Microfluidics (2013-2022) ($MN)
163 RoW BioChips Market Outlook, By Analysis Software (2013-2022) ($MN)
164 RoW BioChips Market Outlook, By Biochip instruments (2013-2022) ($MN)
165 RoW BioChips Market Outlook, By Biochip reagents (2013-2022) ($MN)
166 RoW BioChips Market Outlook, By End User (2013-2022) ($MN)
167 RoW BioChips Market Outlook, By Hospitals and Diagnostics Centers  (2013-2022) ($MN)
168 RoW BioChips Market Outlook, By Biotechnology and Pharmaceutical Companies (2013-2022) ($MN)
169 RoW BioChips Market Outlook, By Academic & Research Institutes  (2013-2022) ($MN)
170 RoW BioChips Market Outlook, By Other End User (2013-2022) ($MN)
171 RoW BioChips Market Outlook, By Application (2013-2022) ($MN)
172 RoW BioChips Market Outlook, By Diagnostic Applications (2013-2022) ($MN)
173 RoW BioChips Market Outlook, By Immune disease diagnostic (2013-2022) ($MN)
174 RoW BioChips Market Outlook, By Neurological diagnostic (2013-2022) ($MN)
175 RoW BioChips Market Outlook, By Cardiac diagnostic (2013-2022) ($MN)
176 RoW BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
177 RoW BioChips Market Outlook, By Drug Discovery (2013-2022) ($MN)
178 RoW BioChips Market Outlook, By Structural Biology (2013-2022) ($MN)
179 RoW BioChips Market Outlook, By Lead Optimization (2013-2022) ($MN)
180 RoW BioChips Market Outlook, By Preclinical and Clinical Trial (2013-2022) ($MN)
181 RoW BioChips Market Outlook, By Process R&D (2013-2022) ($MN)
182 RoW BioChips Market Outlook, By Genomics  (2013-2022) ($MN)
183 RoW BioChips Market Outlook, By Proteomics (2013-2022) ($MN)
184 RoW BioChips Market Outlook, By Other Applications (2013-2022) ($MN)
185 RoW BioChips Market Outlook, By Function (2013-2022) ($MN)
186 RoW BioChips Market Outlook, By Micro-RNA (2013-2022) ($MN)
187 RoW BioChips Market Outlook, By Gene Expression (2013-2022) ($MN)
188 RoW BioChips Market Outlook, By Epigenetic (2013-2022) ($MN)
189 RoW BioChips Market Outlook, By Genotyping (2013-2022) ($MN)
190 RoW BioChips Market Outlook, By Sequence Capture (2013-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials